Our findings for reduced LAG3 in patients with CAD were similar to previous reports by Golden et al. (25), that found initial plasma sLAG3 levels were lower in patients suffering from CAD during follow-up compared to those without CAD, and negatively correlated with the occurrence of future CAD. Here, LAG3 is linked to coronary artery disorder.